Seeking Alpha · RCUS · October 20, 2026

Arcus Biosciences, Inc. (RCUS) Discusses New Data on Casdatifan for Kidney Cancer Across Multiple Lines of Therapy Transcript

Get the app for more

Explore stock news, insights and company research.